CClinicalTrials.gg
CompletedNCT01944930Updated Jan 8, 2021Results posted

Laparoscopic Narrow Band Imaging for Detection of Occult Cancer Metastases

A Phase 1 interventional study of Laparoscopic narrow band imaging and Standard white-light laparoscopy in Gastrointestinal and Gynecologic Malignancies, sponsored by Lahey Clinic. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-01-08.

Sponsored by Lahey Clinic · Phase 1, Interventional, and Diagnostic

Phase
Phase 1
Study type
Interventional
Enrollment
23
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Adult patients evaluated at Lahey Clinic with known or suspected gastrointestinal or gynecologic malignancies and with an indication for diagnostic laparoscopy will be offered participation in the study. The proposed study is a randomized, controlled feasibility trial with crossover design. The study's aim is to evaluate the effectiveness of laparoscopic narrow band imaging (NBI) compared to standard white-light laparoscopy for detection of peritoneal cancer metastases. Study patients will undergo laparoscopic evaluation of the peritoneal cavity using a routine white-light videolaparoscope with the capability of NBI. The order of white-light and NBI laparoscopy will be randomized for each patient (crossover design). Frozen-section histopathology biopsies will be retrieved of all suspicious-appearing abnormalities using best clinical practices. The number of detected peritoneal metastases will be compared between each diagnostic laparoscopy technique. To gauge the rate of potentially missed metastases, peritoneal cancer recurrence will be surveyed through a 1-year follow-up.

02

Conditions studied

  • Gastrointestinal and Gynecologic Malignancies

Browse trials for

03

In context

Neoplasms

9,365 studies on the registry are indexed under Neoplasms; 2,489 are open to participants now.

This study's enrollment of 23 is below the median of 50 across 7,253 interventional studies indexed under Neoplasms.

Browse Neoplasms studies →

Lead sponsor

Lahey Clinic is the lead sponsor of 58 studies on the registry; 4 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 4 (80%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • adult patients
  • diagnosis or suspicion of malignancy of the gastrointestinal or gynecologic tract

Exclusion criteria

Exclusion Criteria:

  • clinical contraindication to diagnostic laparoscopy
05

Study design

Phase
Phase 1
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
23 participants (actual)

Study arms

  • Experimental
    Narrow Band Imaging Laparoscopy First

    Study has single cohort assessed in crossover design. In this arm NBI laparoscopy will be performed first, followed by standard white-light laparoscopy.

    Device: Laparoscopic narrow band imaging · Device: Standard white-light laparoscopy

  • Experimental
    Standard White-Light Laparoscopy First

    Study has single cohort assessed in crossover design. In this arm standard white-light laparoscopy will be performed first, followed by NBI laparoscopy.

    Device: Laparoscopic narrow band imaging · Device: Standard white-light laparoscopy

Interventions

  • DeviceLaparoscopic narrow band imaging

    Also known as: Olympus Evis Exera II CV-180 video processor; Olympus Evis Exera II CLV-180 light source; Olympus EndoEYE surgical videoscope

  • DeviceStandard white-light laparoscopy

    Also known as: Olympus Evis Exera II CV-180 video processor; Olympus Evis Exera II CLV-180 light source; Olympus EndoEYE surgical videoscope

06

What researchers measure

Primary outcomes

  1. Rate of Detectable Peritoneal Metastases

    number of additionally visualized peritoneal lesions

    Time frame: After each Laparoscopy, at time of procedure

07

Results

Posted Jan 8, 2021

Participant flow

Participant flow — Overall Study
MilestoneNarrow Band Imaging Laparoscopy FirstStandard White-Light Laparoscopy First
Started1211
Completed1010
Not completed21

Outcome measures

PrimaryRate of Detectable Peritoneal Metastases

number of additionally visualized peritoneal lesions

Time frame:
After each Laparoscopy, at time of procedure
Reported as:
Number · percentage of lesions
Rate of Detectable Peritoneal Metastases
percentage of lesionsNarrow Band Imaging LaparoscopyStandard White-Light Laparoscopy
Rate of Detectable Peritoneal Metastases02

Adverse events

Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Narrow Band Imaging Laparoscopy First0/10 (0%)0/10 (0%)0/10 (0%)
Standard White-Light Laparoscopy First0/10 (0%)0/10 (0%)0/10 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Narrow Band Imaging Laparoscopy FirstStandard White-Light Laparoscopy FirstTotal
<=18 years000
Between 18 and 65 years101020
>=65 years000
Age, Continuous
Age, Continuous(years)Narrow Band Imaging Laparoscopy FirstStandard White-Light Laparoscopy FirstTotal
Mean70 ± 956 ± 1363 ± 13
Sex: Female, Male
Sex: Female, Male(Participants)Narrow Band Imaging Laparoscopy FirstStandard White-Light Laparoscopy FirstTotal
Female549
Male5611
Region of Enrollment
Region of Enrollment(participants)Narrow Band Imaging Laparoscopy FirstStandard White-Light Laparoscopy FirstTotal
United States101020
08

Study locations

1 site
  • Lahey Clinic
    Burlington, Massachusetts 01805, United States
09

References and documents

Publications

  • Schnelldorfer T, Jenkins RL, Birkett DH, Wright VJ, Price LL, Georgakoudi I. Laparoscopic narrow band imaging for detection of occult cancer metastases: a randomized feasibility trial. Surg Endosc. 2016 Apr;30(4):1656-61. doi: 10.1007/s00464-015-4401-9. Epub 2015 Jul 21. PubMed 26194251 ↗
10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 8, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT01944930
Lead sponsor
Lahey Clinic
Responsible party
Desmond H. Birkett (Chair, Department of General Surgery, Lahey Medical Center, Lahey Clinic) — Principal investigator
First posted
Sep 18, 2013
Start date
Jan 2013
Primary completion
Sep 2014
Completion
Sep 2014
Results posted
Jan 8, 2021
Last update
Jan 8, 2021

Study contacts

Thomas Schnelldorfer, MD
study director · Lahey Clinic
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion